Furthermore, Kaplan-Meier analysis showed that bladder cancer patients with high expression of METTL3 had worse prognosis and shorter survival time, compared with those with low expression of METTL3 (Fig. 1f). Here, METTL3 is linked to urinary bladder cancer.